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T immune system plays a central role before
and during parturition, including the main phy-
siological processes of parturition: uterine con-
tractions and cervical ripening. The immune
system comprises white blood cells and their
secretions. Polymorphonuclear cells and macro-
phages invade the cervical tissue and release
compounds, such as oxygen radicals and
enzymes, which break down the cervical matrix
to allow softening and dilatation. During this
inflammatory process, white blood cells undergo
chemotaxis, adherence to endothelial cells, dia-
pedesis, migration and activation. Factors that
regulate white blood cell invasion and secretion
include cytokines such as tumour necrosis factor
and interleukins. Glucocorticoids, sex hormones
and prostaglandins, affect cytokine synthesis.
They also modulate the target cells, resulting in
altered responses to cytokines. On the other
hand, the immune system has profound effects
on the hormonal system and prostaglandin
synthesis. In animals, nitric oxide has marked
effects on uterine quiescence during gestation. At
the same time, it plays an important role in reg-
ulating the vascular tone of uterine arteries and
has anti-adhesive effects on leukocytes. Cytokines
are found in amniotic fluid, and in maternal and
foetal serum at term and preterm. Several intra-
uterine cells have been shown to produce these
cytoldnes. Since neither white blood cells, cyto-
kines nor nitric oxide seem to be the ultimate
intermediate for human parturition, the immune
system is an additional but obligatory and under-
estimated component in the physiology of
delivery. Scientists, obstetricians and anaes-
thesiologists must thus be aware of these pro-
cesses.
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Introduction
The effect of anaesthesia, stress and pathologi-
cal disorders on the process of labour and the
mode of delivery remains controversial. Because
randomization and clinical research in this field is
limited by ethical considerations, the physiology
of parturition, especially the underlying autocrine,
paracrine and endocrine control must be under-
stood. Therefore, physicians should be familiar
with the physiological processes which con-
tribute to myometrial contractions and cervical
ripening, and must be aware of recent trends
and research.
Until labour, cervical dilatation and particularly
labour are suppressed. During parturition, force-
ful myometrial contractions propel the foetus
through the dilated and ripened cervix and
vaginal tract. Several cascade pathways including
the hormonal system, prostaglandins and the
immune system, contribute to elicit or augment
cervical ripening and labour.
Hormones such as progesterone, oestrogens
and oxytocin may inhibit or induce physiological
processes in the uterus, but they fail to explain
the entire mechanism of parturition. The dis-
covery of prostaglandins and their contribution
to labour was an obstetric revolution with dra-
matic clinical impact. Prostaglandins are obliga-
tory in parturition, but they are not considered
the sole intermediate modulator of this process.
Cervical ripening is an inflammatory process,
2
since polymorphonuclear cells (PMNs) and mac-
rophages are found in abundance in cervical
tissue. Cytokines, which are small intercellular
signal peptides of the immune system, are found
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in varying concentrations in amniotic fluid, foetal several molecules, including (oxygen) radicals;
and maternal serum before and during parturi- proteolytic enzymes such as lysozyme, coi-
tion.-8 They are capable of modulating prosta- lagenase and elastase; and cytokines such as
glandin production.9-12 Several foetal and tumour necrosis factor (TNF) and interleukin-1
maternal cells produce these cytokines.13-6 The (IL-1). Macrophages can release chemotactic
fact that inflammation contributes to delivery is factors for other inflammatory cells. The most
suggested by the finding of irreversible labour important factor is interleukin-8 (IL-8), but leuko-
and cervical ripening with an increased pro- trienes and platelet activating factor (PAF) also
duction of cytokines during intra-uterine infec- have chemotactic properties.
21 On the other
tion.9-11’17 Moreover, intrauterine but not hand, macrophages can release factors that
intraperitoneal bacterial inoculum resulted in inhibit PMN chemotaxis,22’23 resulting in the
preterm delivery within 2 days.
18 accumulation of PMNs around macrophages.
The aim of this article is to propose some During inflammation, the localization of mac-
immunological processes which might play a role rophages in the tissues allows these cells to com-
during cervical ripening and labour. Initially we municate with other adjacent inflammatory cells,
describe the function of the inflammatory cells, endothelial cells and fibroblasts. Of particular
restricted to monocytes and polymorphonuclear interest is the ’decidua-macrophage connection’,
cells (PMNs), and their secretion products because the decidua is enriched with bone-
including oxygen radicals, proteases and cyto- marrow-derived macrophages.24’25 Moreover,
kines. Since the inflammatory cells have to decidual cells have macrophage-like functional
migrate into tissues, a part of this article sum- characteristics, e.g. the production of PAF and
marizes the leucocyte-endothelial cell interaction, several cytokines after endotoxin stimulation.2
Then the physiological result of inflammation of
the cervix and the myometrium is described. In Polymorphonuclear cells: PMNs possess three
the last part of this article a summary is given of major types of granules containing over 20 differ-
the complex interaction of inflammatory and ent enzymes. After stimulation, e.g. by cytokines
neurohumoral pathways. Since research on par- or complement factors, PMNs degranulate with a
turients in this domain is sparse, most of the release of proteases and formation of oxygen
information dealing with PMNs, macrophages, radicals, resulting in tissue destruction. The
cytokines and oxygen radicals originates from in extent of degranulation or respiratory burst b2 vitro studies or from polytraumatized or septic different stimulators has not been clarified fully.
patients or animals. Furthermore, the article has Moreover, after stimulation, PMNs can synthesize
not the intention to be complete, but describes many cytokines.
basic physiological pathways leading to an under- Because of the presence of large amounts of
standing of more specialized articles. PMNs and macrophages in the near-term
cervix,2’28 and their capacity to produce pro-
Th immun system teases, cytokines and oxygen radicals, these cells
must form a requisite step in the inflammatory
The immune system is classically divided into process of ripening the cervix.
an innate branch and an acquired branch. The
latter is mainly composed of lymphocytes and Proteases.. Proteases are discussed under the
immunoglobulins, and the former mainly of heading’cervical ripening’.
monocytes, macrophages, PMNs and natural
killer cells (NK). The protein components of the Oxygen radicals: Oxygen radical formation
innate branch include complement factors and occurs during normal cell function, but in
acute phase proteins (APP).19 The cells of the normal conditions they are neutralized or
innate branch act by producing cytokines, pro- cleared. Sources of oxygen radicals which can
teases and oxygen radicals, result in tissue damage, with respect to parturi-
Monocytes and macrophages: Monocytes and
macrophages roe part of the mononuclear pha-
gocyte system. The macrophage can interact
with its environment through the binding of
tion, include:
Various metabolic steps of eicosanoid metabo-
lism. Toxic oxygen radicals can, by themselves,
stimulate eicosanoid metabolic pathways.29’
molecules to specific functional membrane NADPH dehydrogenase and ubiquinone-
surface receptors, e.g. for cytokines or comple- cytochrome b complex of the mitochondrial
ment fragments. The potent antimicrobial, tumor- electron transport chain. This process is upre-
icidal and tissue destructing activity of stimulated gulated in pathological conditions.
macrophages is explained by the local release of Ischaemia and particularly reperfusion, con-
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comitant with the conversion of the xanthine kines and their possible role during parturition
substrates to uric acid.32 Short-lasting but are discussed here.
recurrent uterine ischaemia, followed by reper-
fusion, occurs during every myometrial con- Interleukin-I. Interleukin-14 exists in two forms,
traction. IL-lz and IL-113, with only 26% homology. Almost
Activation of the PMN (and macrophage) all nucleated cells, but particularly macrophages
plasma membrane NADPH oxido-reductase and monocytes, are capable of producing IL-1.
enzyme complex, in response to endotoxins Stimuli for IL-1 production are: other cytokines
and cytokines.3’4 such as IL-1 itself, TNF and interferons; endo-
toxins; antigen-antibody complexes; and the Fc
Oxygen is converted to its toxic metabolites: regions of IgG and C5a. Inhibitors of IL-1 pro-
viz. superoxide anion (O2-), hydrogen peroxide duction include steroids, prostaglandin E2
(H202) and hypochlorous acid. The major (PGE2) and ot-melanocyte stimulating hormone.
targets of oxygen radicals, with subsequent An engodenously produced IL-1 receptor antago-
destruction, include: lipids
5 (cellysis, cytotoxic nist inhibits the effects of IL-1.
and mutagenic metabolites), nucleic acids36 In vitro, the effects of IL-1 in the cytokine
(mutagenesis and carcinogenesis) and particu- network are the amelioration of the synthesis of
larly proteins7 (destruction, enzymatic dysfunc- TNF, IL-1, IL-2, IL-6, PAF, prostacyclin, PGE2 and
tion). Moreover, adhesion molecules on colony stimulating factor. IL-1 promotes the
leukocytes are upregulated by some oxygen adhesiveness of neutrophils, monocytes and
radicals. Several antioxidants are known; other white blood cells to the endothelial cell by
however, to date none of these agents have been upregulating adhesion molecules on leukocytes,
used extensively in clinical practice. Probably the and their ligands on endothelial cells.
higher frequency of cervix carcinoma present in In vivo IL-1 is pyrogenic and it plays a key role
multiparous compared to nulliparous women is in the interaction of the immune and neuroendo-
explained by the oxygen radicals formation crine systems, with increases of ACTH and corti-
during cervical ripening, costerone production. It causes mobilization of
PMNs from the bone marrow, resulting in a
Cytokines: Cytokines are low molecular weight neutrophilia. Hyaluronic acid and other glycosa-
proteins, secreted in very small amounts by a minoglycans can stimulate IL-1 production, which
variety of cell types. They modify the behaviour in its turn can increase the collagenase and
of other cells and are active in very low con- decrease the metalloproteinase inhibitor levels.
4
centrations. One cytokine may have different Considering the stimulatory effects of IL-1 on
effects, depending on the type of target cell, the leukocytes, cytokine, and prostaglandin produc-
concentration and the interaction with other tion, IL-1 forms a major step in the gestational
cytokines. All cytokines have their specific mem- inflammatory network. This was underscored by
brane receptor(s), which can be shed and some- a study in which almost 100% of preterm mice
times measured in the plasma. Until now it can aborted after systemic
42 or intra-amniotic
43 IL-1
only be assumed that cytokine receptors (and administration. Interleukin-1 receptor antagonist
thus the cytokine effect) found intrauterine prevented this IL-1 induced preterm parturition.
44
during delivery are changed in number, whether
45 by cellular upregulation whether by binding of Interleukin-6. Interleukin-6 can be produced
the receptor from the shedded plasma pool. by almost all nucleated cells. For macrophages,
In vitro TNF, IL-6 and IL-8 are produced by the most potent stimulator of IL-6 production is
several intrauterine cells after stimulation with endotoxin, and for fibroblasts, IL-1 and TNF.
endotoxin or other cytokines. Intrauterine Steroids and oestrogens are strong inhibitors of
sources of cytokines include decidua,14’26’8 IL-6 production in both types of cells. The recep-
inflammatory cells, placental villi,
9 chorion15 and tor of IL-6 is upregulated or downregulated by
endothelial cells. Normal spontaneous labour at steroids, IL-1 and IL-6, depending on the type of
term is associated with a moderate rise in the cell studied.
amount of TNF, IL-1, and especially IL-6 in IL-6, a pleiotropic cytokine, stimulates pros-
amniotic fluid.3-6 This rise is more pronounced taglandin synthesis and it elicits, with the partici-
during intrauterine infection, where a correlation pation of steroids, the production of acute phase
was found between IL-6 and the cytokines TNF proteins by hepatocytes. These liver proteins
and IL-1.
8 This underscores the dependency of have antiprotease, opsonizing and oxygen radical
these cytokines or the same initiating pathways, scavenging properties. It was therefore assumed
In contrast to IL-6, neither TNF nor IL-1 is found that IL-6, in initiating this acute phase response,
in serum during labour. Some important cyto- was responsible for limiting the inflammatory
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reaction to the injured area, viz. the cervix and early delivery than other microbiological tests
the myometrium during parturition. (bacterial culture).6 Since steroid hormones such
IL-6 was found in maternal and foetal serum as progesterone and corticosteroids are capable
and the levels correlated strongly with the dura- of influencing IL-8 production, and prosta-
tion of labour, thus probably also with the extent glandins downregulate the threshold of PMN
of cervical ripening and tissue destruction.7 Since activation after IL-8 stimulation,
52 IL-8 might form
the induction of IL-6 synthesis via mRNA takes the final common step of prostaglandin and
several hours, the serum IL-6 peak found imme- steroid hormone action in parturition.13’14
diately after vaginal delivery implies that inflam- Patients with chorioamnionitis have increased
mation during vaginal delivery is mammal before amniotic fluid levels of IL-1, IL-6, IL-8 and TNF.
birth. Interestingly, considering that IL-6 induces Moreover, this condition is known to be resistant
fever, it was shown that patients with epidural to current available tocolytic therapy, indicating a
analgesia have higher body temperatures after dramatic abortive role of these cytokines.
vaginal delivery than those without epidural
analgesia.
46 However, in these studies the dura- Leucocyte-endothelial cell interaction: Margina-
tion of labour was not included in the statistics tion of leukocytes is attributed to red blood cells
as a dependent variable, although it is known which gather behind leukocytes in capillaries and
that patients with prolonged labour are more push them toward the capillary wall once the
likely to request epidural analgesia than the less vessel diameter exceeds 150% of that of the
affected ’controls’. IL-6 probably has a role in white blood cell. Then, due to low-affinity adhe-
these temperature differences. Another study has sive interaction between leukocytes and vascular
demonstrated a relation between foetal IL-6 and endothelium on the one hand, and to the force
maternal serum IL-6 levels, suggesting a mater- of blood flow on the other hand, leukocytes start
nally induced modification of foetal immune to roll. In inflamed tissue, leukocyte rolling fre-
function and stress response.47 IL-6 measured in quently leads to a stationary state in which the
plasma seems to be a biochemical marker of leukocyte remains firmly attached to the endo-
human preterm labour.
48 thelial surface for more than 30s. These leuko-
cytes can then leave the postcapillary venule by
Tumour necrosis factor. Tumour necrosis extending pseudopodia between apposing endo-
factor49 is mainly produced by macrophages after thelial cells, entering the subendothelial space
stimulation by endotoxin and some cytokines. It and the adjacent interstitial compartment.
5
promotes PGE2 and collagenase production by The basis for a selective appearance of differ-
fibroblasts, induces production of other cyto- ent white cell types in association with different
kines such as IL-1, IL-6 and IL-8, is directly cyto- inflammatory reactions (cervicitis) is thought to
toxic and is a direct stimulus for PMN respiratory be due to the production and release of unique
burst, chemoattractants at the site of inflammation, as
well as to the presence and the number of spe-
Interleukin-8. Interleukin-8 is a strong chemo- cific receptors for these individual chemoat-
tactic agent for PMNs but not for blood mono- tractants on selected cell types.
cytes, a weak inducer of the respiratory burst5 Leukocyte-endothelial cell adhesion is medi-
and a poor stimulator of elastase secretion by ated by glycoproteins that belong to the selectin
PMNs.5This suggests that chemotactic migration family of cell adhesion receptors. L-selectin is
and the release of proteases by PMNs may be constitutively present on leukocytes, E-selectin is
unrelated phenomena. IL-8 is produced by several upregulated on the endothelial surface of post-
cell types including macrophages, fibroblasts, capillary venules by cytokines and P-selectin is
chorion cells, decidual cells,Samnion cells,
16 and present on activated endothelium and platelets.
5
hepatocytes, when appropriately stimulated by Each type of selectin possesses its own receptor,
members of the cytokine network, such as IL-1, however all these ligands are not yet clearly
TNF and endotoxin. In contrast to IL-8, neither defined. Selectins participate in rolling, whereas
TNF nor IL-1 seem to be directly chemotactic, firm adhesion is possible by the interaction of
In contrast to the normal and stable plasma IL- integrins and their ligands.54
8 levels during pregnancy and labour, IL-8 levels Circulating neutrophils are in the resting state
in amniotic fluid increase during gestation. if there is no systemic inflammation, but they
Infection and labour pain may trigger the pro- contain ]3-integrin molecules constitutively on
duction of IL-8 both at term and at preterm their surfaces. After PMN stimulation, these
delivery.4’5 In preterm labour, the IL-8 level in receptors are rapidly induced into a high state of
amniotic fluid is a more accurate predictor of avidity that promotes firm adhesion. At the same
histologic chorioamnionitis, tocolytic efficacy and time, adhesomes, which contain integrins, fuse
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with the plasma membrane, resulting in upregu- tice that myometrial contractions contribute
lation of extracellular matrix receptors, mechanically to cervical dilatation. Lumbar epi-
Since rolling leads to intimate contact between dural analgesia transiently reduce uterine con-
neutrophils and endothelial cells, this process tractility, but the rate of cervical dilatation is not
should allow neutrophils to become activated by affected.1’59’6 This underscores the relative inde-
agents expressed on the endothelial cell surface pendence of both processes and the clinically
or by substances released from cells lying imme- negligible effect of epidural analgesia on the dila-
diately outside the vasculature. These agents tation of the cervix.
include PAF and oxygen radicals. Interestingly, The connective tissue of the cervix is com-
neutrophils with impaired L-section are able to posed of collagen, elastin, numerous fibroblasts
adhere and emigrate during stasis, possibly and relatively few smooth muscle cells, separated
bypassing the need for selectin for neutrophil by ground substance, which form a strong
adherence during uterine contractions, barrier against foetal loss and ascending bacterial
Endothelial cells (EC) can be stimulated55 by infection.1 An increase in vascularity, water
hydrogen peroxide, thrombin and histamine. This content and extensive changes in the connective
leads to the transport of Weibel Palade bodies, tissue are responsible for clinically recognized
which contain P-selectin. Hydrogen peroxide can cervical softening, effacement and dilatation are
induce PAF formation on the EC surface. PAF is encountered as pregnancy progresses. Near term,
translocated to the membrane but not released. PMN and macrophages invade cervical connective
This transient co-expression of P-selectin and PAF tissue,
28 leading to a local inflammation de-
leads to more efficient granulocyte stimulation, scribed as ’cervicitis’.
and may also lead to cytokine secretion by adher-
ing monocytes. Thus EC stimulation is a fast, Ground substance: Proteoglycans form the main
receptor-synthesis-independent response occur- component of the ground substance. They are
ring within minutes, leading to leukocyte adher- made up of several glycosaminoglycans (GAGs)
ence without obligatory PMN activation, connected to a protein core. These GAGs
Endothelial cells can be activated56 by endo- contain a large number of sulphate groups and
toxin and cytokines such as TNF, IL-1 and IL-8, are arranged around the collagen fibrils. Their
leading to de novo expression of E-selectin and function is not well understood, but they modify
adhesion molecules including the endothelial the physical properties of collagen and determine
leukocyte adhesion molecule ELAM-1 (with a the water content of the cervix. Hyaluronic acid
peak at 4-6 h after stimulation). PAF may also is an important GAG and is associated with the
serve as a necessary cofactor, whereas IL-8 may capacity of tissue to retain water. Compared to
also act as a secondary signalling agent. Shedding other GAGs, it binds least strongly with collagen,
of ELAM-1 (soluble ELAM-1) serves as a conven- and thus will act to destabilize the collagen
tional neutrophil chemoattractant. After binding fibrils. Just before labour, the concentration of
its neutrophil ligand, ELAM-1 recruits participa- GAGs increases due to increased synthesis, and
tion of additional adhesion molecules by trigger- during the active phase of labour a decrease in
ing the activation of integrins on the surface of cervical proteoglycans is noted.62 This drop
neutrophils, all of which participate in diapedesis, results in a facilitation of collagen breakdown
As the number of PMNs and macrophages in and an increase in cervical water content. Oxy-
the near-term cervix increase spectacularly,2’28 the radicals can elicit the breakdown of ground sub-
cascade mechanisms eliciting tissular white blood stance proteins including hyaluronic acid,6
cell recruitment and activation as described whereas PMN-derived enzymes for ground sub-
above must be activated before and during stance degradation include cathepsins, elastase
delivery. The result of these processes is the and lysozyme. To make it even more compli-
benign softening and dilatation of the cervix, as a cated, soluble hyaluronic acid can induce the
result of local macrophage and PMN activations production of some cytokines including TNF64
permitting the passage of the foetus, and IL-1,65 and can inhibit oxygen radical forma-
tion and phagocytosis by macrophages.
Cervical ripening Collagen: Cervical collagen, 70% type I and 30%
In sheep, cervical division of the cervix from type III,
6 is resistant to most extracellular pro-
the rest of the uterus still resulted in cervical teases, except collagenase and PMN or macro-
ripening during labour, suggesting that both phage elastase. During pregnancy, mature
processes can occur relatively independently.57 collagen, with many cross links is broken down
Cervical PGE2 production increases58 in response and replaced with new collagen which is more
to stretching and it is known from clinical prac- amenable to rapid breakdown at the time of
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parturition. The amount of intact collagen sine 3’5’-cyclic monophosphate (cGMP). It inhi-
decreases 70% in comparison with concentra- bits leucocyte adhesion to endothelial cells75 and
tions in the non-pregnant cervix.7 Local cervical the production of endothelin.7 NO is syn-
and plasma collagenase enzyme activity is thesized from the ,-arginine molecule, a reaction
mammal during the active second phase of that is catalysed by the enzyme NO-synthase,74
labour. This collagenase found during labour is leaving citrulline as a stable marker of NO syn-
synthesized by cervical PMNs, and to a lesser thesis. Nitrite and nitrate are stable end-products
degree, by cervical fibroblasts.* It is released as ofNO metabolism. A first subtype of NO-synthase
a latent procollagenase, which in turn has to be is a constitutive, cytosolic calcium-dependent
cleaved by another protease before it is active, enzyme, releasing NO after direct stimulation
Tertiary granules of PMNs contain gelatinase, with calcium ionophores, acetylcholine, brady-
which hydrolyses denatured collagen and breaks kinine, lipopolysaccharide, thrombin, PAF and
down laminin and fibronectin. This enzyme electrical stimulation.74’77 A second subtype of
increases consistently with the influx of PMNs. NO-synthase is an inducible Ca-independent
Interestingly, serum collagenase levels are higher enzyme which is found following cellular contact
in parturients with ripe cervices who go into with cytokines. This upregulation is strongly
preterm labour than in women with unripe cer- inhibited by many agents including glucocorti-
vices who deliver at term.9 coids, IL-4 and IL-10.23;78
In rodents, NO is produced by nerves, blood
Elastin: The synthesis and degradation of elastin cells and decidual cells during gestation.
79-1
is not well understood,
7 but PMN-derived tissue Nitrate, a stable NO metabolite, plasma cGMP
elastate levels gradually increase during preg- and urinary cGMP are increased in the gravid
nancy, and double again during labour. More- rat.
82 At the end of gestation and during
over, PMN-derived elastase can degrade virtually labour, NO production and the sensitivity of
all extracellular matrix 2roteins, including col- smooth muscle to NO is substantially reduced,
lagen and proteoglycans, which suggests that NO may contribute to the
In summary, as labour progresses, the increase maintenance of uterine quiescence, maternal
in proteases outpace the local content of enzyme vasodilatation and uterine immune suppression
inhibitor, leading to a net degradation of con- during gestation but not during labour.79-m
nective tissue. The major sources of oxygen Administration of an inhibitor of NO-synthase
radicals and proteases are PMNs and macro- caused hypertension and growth retardation, but,
phages which in their turn are attracted and acti- the gestational duration was not affected.8
vated by cytokines. Hormones and prostaglandins In humans, constitutive NO-synthase is expres-
alter the sensitivity of these cells to several cyto- sed by the syncytiotrophoblast, and inducible
kines. For example, prolactin increases phago- NO-synthase can be present on placental chor-
cytosis by PMN and macrocytes,
7 possibly ionic villi and the basal plate of the human
leading to accelerated normalization of the cervix uterus.4 The role of NO during gestation and
postpartum, labour in humans remains to be determined.
Labour
Identification of hormone receptors, e.g. the
oxytocin receptor, and the discovery of regulatory
intracellular proteins, helped to clarify the
mechanism of the action of relaxing and contract-
ing substances on the myometrium. No studies
However, in a small study, transdermal nitrates,
which are potent NO sources, seem to inhibit
premature labour.85
Hormones, prostaglandins and the
immune system
Hormones and prostaglandins are necessary
on the direct effects of cytokines on uterine for delivery. Their role during parturition is sum-
smooth muscle cells have been published yet. marized below, especially with respect to the
TNF and IL-1 stimulate the production of endo- immune system.
thelins, which are potent uterotonics secreted by
amnion and endothelial cells, and these cytokines Oestrogens: The foetus supplies the placenta
promote the production of several prosta- with precursors for oestrogen synthesis, and
glandins,w Endothelins stimulate the production oestrogens are then released into the maternal
of arachidonic acid by monocytes or macro- circulation. Maternal serum levels of oestrogens
phages.72’7 gradually increase during normal pregnancy.
Substances known to augment oestrogen syn-
The role of nitric oxide: Nitric oxide (NO)74 thesis include intracellular cAMP, human chor-
relaxes smooth muscle cells by elevating guano- ionic gonadotropin (hCG), ACTH and insulin,
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whereas glucocorticoids attenuate oestrogen iban, an oxytocin antagonist, decreased the con-
production, traction frequency in patients in preterm labour,
Oestrogens are thought to be essential in the oxytocin appears to play a role in the main-
preparation, rather than the mechanism, of the tenance of contractions in these women.9
initiation of birth. In sheep, oestrogens enhance
oxytocin responsiveness of the uterus, cause pre- The cytokine-neuroendocrine interaction: The
mature parturition, stimulate myometrial activity, effects of cytokines on the neuroendocrine
increase intracellular calcium and the myometrial system are complex.91 The major site of produc-
content of proteins involved in contraction, tion of cytokines is the locus of inflammation,
increase a- and reduce I-adrenergic receptor viz. the cervix. The cytokines can have their
content, stimulate prostaglandin production and effect either locally, called a paracrine effect, or
reverse the inhibitory effects of progesterone, at a distance, called an endocrine effect. For
Oestrogens can modulate the synthesis of glyco- example, endotoxin or low plasma levels of
aminoglycans and can increase the collagen turn- some cytokines have an effect on the hypothala-
over in the uterus. However, conflicting results mus and the pituitary gland.92 Nevertheless, little
on the efficacy of oestrogens with respect to cer- information is available about neuroimmune
vical ripening have been reported,s interactions during pregnancy, particularly about
the influence of stress and pain during labour on
Progesterone.. Progesterone production by the this neuroimmune function.
corpus luteum starts early in pregnancy. There- The hypothalamic-pituitary-adrenal axis is
after, progesterone is synthesized by the tropho- stimulated by IL-1, TNF and to a lesser degree IL-
blast. Its production increases with placental size, 6, mainly via release of corticothrophin-releasing
resulting in a rise in maternal plasma concentra- hormone,
9 a direct action on the adrenal gland
94
tion to reach a plateau at about 32 weeks’ gesta- and probably also on the pituitary gland. This
tion. Placental progesterone production is results in an increased production of glucocorti-
thought to operate maximally and at a rate deter- coids.
mined by the cholesterol supply from maternal Severe infection and inflammation are fre-
circulation, hCG, [3-adrenergic agonists and cate- quently accompanied by an inhibition of repro-
cholamines have little effect on progesterone ductive function.95 Cytokines such as IL-1 and
synthesis.
87 TNF depress the hypothalamic-pituitary-gonadal
Progesterone can restrict rises in intracellular axis via the hypothalamus (gonadotrophin-releas-
calcium, restrict the coupling efficiency of [1- ing hormone), the pituitary (LH, FSH) and the
r 96 adrenergic receptors to enhance cAMP produc- ovary (ste oidgenesis). Administration of IL-1
tion, or inhibit uterine prostaglandin production, leads to increased oxytocin levels and increases,
The ’progesterone withdrawal’ hypothesis with at least in vitro, the uterine myometrial response
concomitant oestrogen secretion was based on to oxytocin. However, it should be noted that in
the dramatic decrease in plasma levels of proges- contrast to IL-6, neither TNF nor IL-1 are found
terone just before parturition in several mamma- during normal parturition into the patients’
lian species. In humans, however, no reduction serum.
of plasma progesterone has been observed Glucocorticoids and oestrogens
97 can exert a
before the onset of labour. On the other hand, negative effect on the immune system, because
inhibition of progesterone synthesis or surgical they inhibit the synthesis of IL-1, TNF, IL-2, IL-6
progesterone withdrawal result in abortion or and IL-8 by macrophages. Progesterone is a
98 increased sensitivity of the myometrium to utero- potent anti-inflammatory agent. Antiprogestins
tonic agents, ameliorate cervical ripening, as these agents
99 promote PMN influx, probably as a result of
Oxytocin: Oxytocin promotes the production of a neutralization of an inhibitory effect of pro-
prostaglandins<s9 by a protein kinase C depen- gesterone on IL-8 production by choriodecidual
dent mechanism, and oxytocin administration cells.14
induces labour in near term parturients.
However, plasma oxytocin concentrations do not Prostaglandins.. Some prostaglandins given by
increase initially during labour, and oxytocin mouth, intravenously or by cervical instillation,
does not induce myometrial gap junctions or evoke myometrial contractions, cervical ripening
cervical ripening. Plasma oxytocin levels do not and abortion or delivery at any stage of preg-
increase until late in parturition, so the increase nancy. Inhibitors of prostaglandin synthesis
of membrane oxytocin receptors by an unknown lengthen the induction-abortion time interval
mechanism upregulates the effects of oxytocin after instillation of hypertonic saline, or lead to
during the second stage of labour.89 Since antox- prolongation of gestation.
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Arachidonic acid in tissue is present in an
esterified form in glycerophospholipids, which
form 10 to 30% of the total fatty acid content of
the (intra)uterine tissues. The formation of free
arachidonic acid is considered to be a rate-limit-
ing stop in prostaglandin synthesis. In some
tissues, however, the rate of prostaglandin pro-
duction is at least partially regulated by the rate
of conversion of arachidonic acid to prosta-
glandins.
8 Moreover, not all arachidonic acid is
necessarily directed toward prostaglandin and
prostanoid biosynthesis, because a significant
proportion of it may be converted by lipoxy-
genase to form leukotrienes and hydroxyeico-
satetraenoic acids, by epoxygenase to form
epoxides and, more importantly, to reincorpora-
tion in the structural fat of cell membranes.
During the production of prostaglandins from
arachidonic acid, oxygen radicals are formed.
These radicals can influence the cyclooxygenase
enzyme, altering PG formation.29’3
Two genes, for cyclooxygenase, termed cox-1
and cox-2, have been cloned and expressed in
functional form. The cox-1 gene is expressed
ubiquitously in vivo and in vitro, whereas the
cox-2 gene is expressed at very low levels in
normal tissues. The expression of the cox-2 gene
is induced by lipopolysaccharide or IL-1. The
cyclooxygenase undergoes irreversible self-inacti-
vation, so that modulation of activity depends on
continued synthesis of the enzyme,
lm Intrauter-
ine bacterial inoculation in mice led to preterm
delivery, accompanied by induction of ribonu-
cleic acid transcript for several cytokines and for
cox-2.18 Cox-2 knockout mice are infertile, which
may at least in part be related to the important
role which prostaglandins play in implantation,
pregnancy and lactation.
2
Bacterial toxins, particularly IL-1, TNF and IL-6,
in concentrations found in amniotic fluid during
parturition,
1 increase prostaglandin formation by
amnion cells and chorion laeve cells (PGE2,
PGFaz),
12 endometrial stromal cells which are the
progenitors of the decidual cells (PGF2a,
PGE2)13’14 and myometrial muscle cells (PGI2,
PGE2 and PGF2).9 Other cytokines, such _as IL-
105 43 106 4 and transforming growth factor-132 sup-
press prostaglandin production by monocytes.
Therefore, infection as a causative event of
labour has led to the theory that part of the
problem of prematurity is a problem of infec-
tion.1’11’17 Some studies indicate a modulating
effect of prostaglandins on immune cells with
respect to cytokine production, or response
threshold to some cytokines.
14 Recently, utero-
globulin (Clara Cell protein, CCl0, protein 1) is
found in abundance in amniotic fluidma and
probably originates from the foetal lung. It has
potent anti-inflammatory properties by inhibiting
tl 109 phospholipase A2 and PAF genera ’on;
however, its exact role in parturition is under
investigation.
Conclusion
The physiology of parturition is at least par-
tially explained by the contribution of the
immune system. Several cascades seem to play a
role, but no pathway is totally independent.
Before therapeutic intervention aimed at mod-
ulating one or more cascades to reduce cervical
ripening and thus to prevent prematurity can be
considered, one must be certain of the side
effects of such therapy. For example, antibodies
against ELAM will dramatically reduce PMN in-
vasion of the cervix, inhibiting cervical softening
of dilatation. However, the resistance of the
mother against bacterial invasion will be reduced
simultaneously, leading to bacteraemia with
potentially disastrous effects on both the mother
and foetus.
Extensive research is necessary to understand
the pathophysiology of parturition to allow
appropriate interference with these physiological
pathways. Moreover, the pathophysiological back-
grounds of several gestationally related diseases,
including haemolysis, elevated liver enzymes, low
platelet or HELLP syndrome, (pre)eclampsia or
recurrent abortion, need to be unravelled.
Further research to determine the effects of
analgesia and anaesthesia on this immuno-obste-
tric system will also identify more accurately the
hazards or benefits of these techniques on foetal
and maternal well-being.
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